IP Library Granted Patent US 9,844,462
Granted Patent B2
US 9,844,462 · App. 14/610,197 · Granted Dec 19, 2017

Internal shunt and method for treating glaucoma

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,844,462
App. No.
14/610,197
Granted
Dec 19, 2017
Kind
B2
Abstract

A surgical technique and device wherein an indwelling tube is placed in the eye of a patient having glaucoma. The tube diverts aqueous humor from the anterior chamber to the suprachoroidal space from which it is removed by blood flowing in the choroidal and uveal tissues. This decreases the intraocular pressure.

Claims (10)

1. A method of treating glaucoma, comprising:

providing an elongated tube comprising a first end having at least one inflow port, at least one outflow port and an internal fluid passageway communicating between the at least one inflow port and at least one outflow port;

forming a flap in a sclera of an eye;

folding back the flap;

removing tissue from the sclera to form a scleral lake;

inserting the tube into the eye so that the tube diverts fluid from the scleral lake to a suprachoroidal space of the eye.

2. A method as in claim 1 , further comprising suturing the tube to the eye.

3. A method as in claim 1 , further comprising cutting through a scleral bed formed when the flap in the sclera is folded back.

4. A method as in claim 1 , further comprising removing a trabeculectomy specimen.

5. A method as in claim 4 , wherein removing the trabeculectomy specimen creates a direct communication to the anterior chamber from the scleral lake.

Assignments (4)
CONFIRMATORY DEED OF ASSIGNMENT EFFECTIVE APRIL 8, 2019 Recorded Dec 10, 2019
From: NOVARTIS AG
To: ALCON INC.
Reel/Frame 051454/0788 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 13, 2016
From: TRANSCEND MEDICAL, INC.
To: NOVARTIS AG
Reel/Frame 038967/0487 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 14, 2015
From: YABLONSKI, MICHAEL (ANNE YABLONSKI SUISSA, EXECUTOR)
To: YABLONSKI, JUDITH
Reel/Frame 035408/0986 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 14, 2015
From: YABLONSKI, JUDITH
To: TRANSCEND MEDICAL, INC.
Reel/Frame 035408/0997 →